Mymetics Corp (MYMX)

[bow-tie]

Vaccine adjuvants: Understanding the ... - ScienceDirect
www.sciencedirect.com › science › article
May 27, 2019 · Among these, CpG-B class, e.g., CpG 1018, 1826, 2007, is the most commonly used one in pre-clinical and clinical trials . HEPLISAV-B, a hepatitis B vaccine approved by the FDA in 2017, is the first vaccine adjuvanted with CpG ODN 1018 .

https://www.researchgate.net/publication/338945184_Vaccination_with_virosomally_formulated_recombinant_CyRPA_elicits_protective_antibodies_against_Plasmodium_falciparum_parasites_in_preclinical_in_vitro_and_in_vivo_models